Amplicon details |
||
Amplicon: |
173 bp | |
1 ggatctcctg tcatctcacc ttgctcctgc cgagaaagta tccatcatgg 51 ctgatgcaat gcggcggctg catacgcttg atccggctac ctgcccattc 101 gaccaccaag cgaaacatcg catcgagcga gcacgtactc ggatggaagc 151 cggtcttgtc gatcaggatg atc |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
DD087808.1 | emblrelpat | JP 2004530418-A/14: Method for prod... | 12085 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD087809.1 | emblrelpat | JP 2004530418-A/15: Method for prod... | 12079 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD087810.1 | emblrelpat | JP 2004530418-A/16: Method for prod... | 13002 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD087811.1 | emblrelpat | JP 2004530418-A/17: Method for prod... | 13905 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD087812.1 | emblrelpat | JP 2004530418-A/18: Method for prod... | 15430 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD096967.1 | emblrelpat | COMPOSITIONS AND METHODS FOR HIGH-L... | 12701 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD096968.1 | emblrelpat | COMPOSITIONS AND METHODS FOR HIGH-L... | 12109 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD096971.1 | emblrelpat | COMPOSITIONS AND METHODS FOR HIGH-L... | 12704 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD096972.1 | emblrelpat | COMPOSITIONS AND METHODS FOR HIGH-L... | 11273 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD096995.1 | emblrelpat | COMPOSITIONS AND METHODS FOR HIGH-L... | 12052 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD096997.1 | emblrelpat | COMPOSITIONS AND METHODS FOR HIGH-L... | 11216 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD098251.1 | emblrelpat | Therapeutic binding molecules. | 8687 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD098252.1 | emblrelpat | Therapeutic binding molecules. | 8687 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD098253.1 | emblrelpat | Therapeutic binding molecules. | 9400 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD098254.1 | emblrelpat | Therapeutic binding molecules. | 9362 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD098717.1 | emblrelpat | A method to increase antigens produ... | 7491 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD098718.1 | emblrelpat | A method to increase antigens produ... | 7478 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD103159.1 | emblrelpat | RECOMBINATION METHOD. | 3997 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD107525.1 | emblrelpat | Novel Recombinant Gene Expression M... | 7873 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
DD107526.1 | emblrelpat | Novel Recombinant Gene Expression M... | 7943 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.